Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-050842
Filing Date
2012-09-17
Accepted
2012-09-17 17:56:39
Documents
1
Period of Report
2012-09-17

Document Format Files

Seq Description Document Type Size
1 FORM4-STOCKPURCHASE rrd356345.html 4  
1 FORM4-STOCKPURCHASE rrd356345.xml 4 3555
  Complete submission text file 0001181431-12-050842.txt   5179
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 121095749